← Leaderboards
Richard C Allen
Titan Pharmaceuticals, Inc.
$1,159,611
Attributed
$1,159,611
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,159,611 · 1
By mechanism
R44$1,159,611 · 1
Top collaborators
No co-investigators on record.
Most similar at Titan Pharmaceuticals, Inc.
Same institution · by research overlap
- Katherine Beebe Devarney$27,187,371
- Rajesh A Patel$3,697,500
- Sunil P Sreedharan$247,500
Others in their field
Top investigators on “Cell Line”
- David Heimbrook · Leidos Biomedical Research, Inc.$236,973,333
- Dennis R. Burton · Scripps Research Institute$203,685,614
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$177,001,772
- John M Lachin · George Washington University$118,672,444
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- Fred M Gordin · Social And Scientific Systems, Inc.$82,802,056
Research focus
Cell LineCell TransplantationClinical ResearchClinical Trial Phase IDopamineDosageGelatinHuman SubjectHuman Therapy EvaluationImplantMacaca MulattaMicrocapsuleNervous System TransplantationNonhuman Therapy EvaluationParkinson'S Disease